AVNS Comptes : Analyse IA Avanos Medical Inc

Accueil

Stock

AVNS

AVNS Financier

Avanos Medical Inc

$14.9

0.94%

$0.14

À la fermeture : Feb 13, 16:00:00 GMT-5

$14.9

Post-Marché: Feb 13, 20:00:00 GMT-5

Aperçu Prévision Gagner Dividendes Comptes financiers

Revenus

État de situation

Flux de trésorerie

Annuel

Trimestriellement

AVNS Revenu

Chiffres en millions de dollars américains. L'exercice financier va de février à janvier.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenus	699	687	673	820	744	714
Croissance des revenus (H/H)	3%	2%	-18%	10%	4%	2%
Coût des ventes	334	306	293	370	380	341
Bénéfice brut	365	381	379	450	364	373
Vente, Général et Administration	316	314	331	339	300	332
Recherche et développement	22	26	27	30	32	34
Frais d'exploitation	334	336	372	374	347	419
Autres revenus (charges) non opérationnels	--	--	--	--	--	--
Bénéfice avant impôts	-487	-403	-7	65	5	-60
Charge d'impôt sur le revenu	-19	-17	2	14	0	-33
Bénéfice net	-468	-392	-61	50	5	-27
Croissance du bénéfice net	-3,220%	543%	-222%	900%	-119%	-40%
Actions en circulation (diluées)	46.4	46	46.6	47.3	48.6	47.8
Variation des actions (H-H)	-1%	-1%	-1%	-3%	2%	0%
EPS (dilué)	-10.1	-8.52	-1.32	1.07	0.11	-0.57
Croissance du EPS	-3,161%	545%	-223%	873%	-119%	-41%
Flux de trésorerie libre	74	82	14	71	66	-22
Flux de trésorerie libre par action	--	--	--	--	--	--
Marge brute	52.21%	55.45%	56.31%	54.87%	48.92%	52.24%
Marge opérationnelle	4.43%	6.4%	1.04%	9.26%	2.15%	-6.44%
Marge bénéficiaire	-66.95%	-57.05%	-9.06%	6.09%	0.67%	-3.78%
Marge du flux de trésorerie libre	10.58%	11.93%	2.08%	8.65%	8.87%	-3.08%
EBITDA	71	89	53	123	54	-4
Marge EBITDA	10.15%	12.95%	7.87%	15%	7.25%	-0.56%
D&A pour le résultat opérationnel	40	45	46	47	38	42
EBIT	31	44	7	76	16	-46
Marge EBIT	4.43%	6.4%	1.04%	9.26%	2.15%	-6.44%
Taux d'imposition effectif	3.9%	4.21%	-28.57%	21.53%	0%	55%

Statistiques clés

Clôture préc.

$14.76

Prix d'ouverture

$14.83

Plage de la journée

$14.83 - $15.21

Plage de 52 semaines

$9.3 - $16.75

Volume

411.1K

Volume moyen

532.5K

BPA (TTM)

-10.18

Rendement en dividend

Capitalisation boursière

$691.6M

Qu’est-ce que AVNS ?

Avanos Medical, Inc. is a medical technology company, which engages in delivering clinically superior medical device solutions and products to healthcare providers and patients. The company is headquartered in Alpharetta, Georgia and currently employs 2,227 full-time employees. The company went IPO on 2014-10-21. The company offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. Specialty Nutrition Systems portfolio of products includes enteral feeding, which consist of MIC-KEY enteral feeding tubes and Corpak patient feeding solutions, and Neonate solutions feeding products consist of NeoMed neonatal and pediatric feeding solutions. The company also includes TKO, an anti-reflux needleless connector technology, which is used in Neonatal and Pediatric Intensive Care Units. The Pain Management and Recovery portfolio of products includes surgical pain and recovery products such as ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems and Radiofrequency Ablation solutions, which provide invasive pain relief therapies, such as COOLIEF, Trident and ESSENTEC RFA products.



Fonctionnalités

Copilote IA pour actions et cryptomonnaies

Prédiction des prix

Suivi des collectes de fonds

Thèmes

Comparaison de cryptomonnaies

Ressources